Several antihistaminic pharmacodynamic aspects, especially of Eprozinol
Duchene-Marullaz, P.; Rispat, G.; Perriere, J.P.
Therapie 26(1): 155-162
1971
ISSN/ISBN: 0040-5957 PMID: 4396627 Document Number: 40976
Document emailed within 1 workday
Related Documents
Marmo, E. 1983: Pharmacodynamic aspects of theophylline La Clinica Terapeutica 106(2): 87-94Covino, B.G. 1984: Pharmacodynamic and pharmacokinetic aspects of local anesthetics Annales Chirurgiae et Gynaecologiae 73(3): 118-122
Carbon, C.; Crémieux, A.C.; Fantin, B. 1993: Pharmacokinetic and pharmacodynamic aspects of therapy of experimental endocarditis Infectious Disease Clinics of North America 7(1): 37-51
Gjermo, P. 1978: Pharmacodynamic aspects of the plaque inhibiting effect of chlorhexidine Zwr 87(7): 337-338
Reid, J.L. 1995: Pharmacokinetic and pharmacodynamic aspects of the choice of components of combination therapy Journal of Human Hypertension 9(Suppl 4): S19-S23
Orzechowska-Juzwenko, K. 1998: Optimizing pharmacotherapeutic aspects of pharmacokinetic and pharmacodynamic drug properties in the elderly Przeglad Lekarski 55(11): 607-610
Novotný, P. 1973: An antihistaminic with antidepressant action Casopis Lekaru Ceskych 112(41): 1276-1277
Alekhin, E.K.; Krasilova, I.L. 1998: The immunotropic activity of H1 antihistaminic preparations Eksperimental'naia i Klinicheskaia Farmakologiia 61(2): 79-86
Römer, D.; Weidmann, H. 1966: Pharmacological studies on the new antihistaminic Tavegil Die Medizinische Welt 51: 2791-2794
Dry, J.; Pradalier, A. 1977: Current status of antihistaminic therapy La Revue du Praticien 27(59): 4145-6 4151-4
Bindslev-Jensen, C.; Frølund, L.; Svendsen, U.G. 1989: Cetirizine. a new non-sedative antihistaminic agent Ugeskrift for Laeger 151(16): 1011-1012
Beritić, T. 1971: Clinical evaluation of a new antihistaminic agent--Tavergyl Lijecnicki Vjesnik 83(9): 1065-1070
Rewari, S.; Gupta, U. 1999: Modification of antihistaminic activity of cetirizine by nimesulide Journal of the Association of Physicians of India 47(4): 389-392
Cheng, H.C.; Woodward, J.K. 1982: A kinetic study of the antihistaminic effect of terfenadine Arzneimittel-Forschung 32(9a): 1160-1166
Hajós, M. 1971: A new antihistaminic drug (Tavegyl) in allergic diseases Therapia Hungarica 19(2): 67-69
Kaminka, M.E.; Tupikina, S.M.; Mashkovskiĭ, M.D. 1983: Effect of antihistaminic preparations on gastric secretion in rats Biulleten' Eksperimental'noi Biologii i Meditsiny 95(5): 44-46
Marozzi, F.J.; Kocialski, A.B.; Malone, M.H. 1970: Studies on the antihistaminic effects of thymoquinone, thymohydroquinone and quercetin Arzneimittel-Forschung 20(10): 1574-1577
Mashkovskiĭ, M.D.; Shvarts, G.I. 1979: Antihistaminic and antiserotonin properties of new complex tropine esters Farmakologiia i Toksikologiia 42(1): 3-7
Shaĭdrov, V.V.; Ionov, I.D. 1988: Evaluation of the immunotoxicity of sulfanilamide, anti-inflammatory and antihistaminic preparations Farmakologiia i Toksikologiia 51(3): 82-84
Rogóz, Z.; Skuza, G.; Sowińska, H. 1981: The effect of the antihistaminic drugs on the central action of 5-hydroxytryptophan in mice Polish Journal of Pharmacology and Pharmacy 33(4): 459-465